In this role, Ms Bielefeld-Sevigny will be responsible for driving expansion of the reagents portfolio for its bio-discovery business. Most recently, Ms Bielefeld-Sevigny, served as director of molecular pharmacology for bio-discovery’s reagents business at PerkinElmer.
Ms Bielefeld-Sevigny has received her PhD from the Institute for Microbiology, Dusseldorf, Germany, and is the author of numerous scientific publications.
Richard Eglen, president of bio-discovery at PerkinElmer, said: “Martina is a proven scientific, operational and business leader and has demonstrated outstanding results in her R&D role in recent years. We are confident that her commitment to developing and leading high performance initiatives will help to grow PerkinElmer’s role as an industry leader in providing integrated solutions to meet emerging customer needs.”